Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCS
2676
DELISTED
Steelcase
SCS
| $726K | ﹤0.01% |
94,100
-45,324
| -33% | -$343K |
|
2677
Kopin
KOPN
$652M
| $725K | ﹤0.01% |
337,164
+55,100
| +20% | +$82.6K |
|
2678
Avantis International Equity ETF
AVDE
$18.2B
| $723K | ﹤0.01% |
12,600
+800
| +7% | +$46.2K |
|
|
GDEN
2679
DELISTED
Golden Entertainment
GDEN
| $723K | ﹤0.01% |
17,296
-34,450
| -67% | -$1.44M |
|
|
NAGE
2680
Niagen Bioscience
NAGE
$271M
| $723K | ﹤0.01% |
460,539
+33,339
| +8% | +$49.8K |
|
2681
Stoneridge
SRI
$195M
| $719K | ﹤0.01% |
38,119
-21,600
| -36% | -$379K |
|
2682
nLIGHT
LASR
$3.88B
| $715K | ﹤0.01% |
46,400
-82,300
| -64% | -$1.01M |
|
2683
Marten Transport
MRTN
$1.21B
| $714K | ﹤0.01% |
33,200
-77,050
| -70% | -$1.62M |
|
|
SEVN
2684
Seven Hills Realty Trust
SEVN
$171M
| $713K | ﹤0.01% |
69,492
+8,392
| +14% | +$81.3K |
|
2685
Patrick Industries
PATK
$2.74B
| $712K | ﹤0.01% |
+13,353
| New | +$629K |
|
2686
Shattuck Labs
STTK
$675M
| $711K | ﹤0.01% |
227,800
-20,367
| -8% | -$59.1K |
|
2687
Nkarta
NKTX
$150M
| $710K | ﹤0.01% |
324,000
+80,700
| +33% | +$355K |
|
|
DALN
2688
DELISTED
DallasNews
DALN
| $709K | ﹤0.01% |
182,251
-1,800
| -1% | -$7.39K |
|
2689
AdvisorShares Pure US Cannabis ETF
MSOS
$858M
| $708K | ﹤0.01% |
+127,762
| New | +$701K |
|
2690
Bio-Rad Laboratories Class B
BIO.B
| $705K | ﹤0.01% |
1,900
| – | – |
|
|
DFSV
2691
Dimensional US Small Cap Value ETF
DFSV
$8.19B
| $704K | ﹤0.01% |
27,400
-27,298
| -50% | -$668K |
|
|
DEA
2692
Easterly Government Properties
DEA
$1.13B
| $703K | ﹤0.01% |
19,407
-58,393
| -75% | -$2.05M |
|
2693
OmniAb
OABI
$287M
| $703K | ﹤0.01% |
+139,859
| New | +$567K |
|
|
LIAN
2694
DELISTED
LianBio American Depositary Shares
LIAN
| $703K | ﹤0.01% |
308,500
+12,300
| +4% | +$28.3K |
|
2695
Scholar Rock
SRRK
$5.67B
| $700K | ﹤0.01% |
92,900
-47,500
| -34% | -$359K |
|
2696
Instil Bio
TIL
$48.3M
| $699K | ﹤0.01% |
63,401
+22,535
| +55% | +$275K |
|
2697
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$800M
| $697K | ﹤0.01% |
22,800
-26,053
| -53% | -$805K |
|
2698
Opko Health
OPK
$985M
| $697K | ﹤0.01% |
321,353
-1,366,790
| -81% | -$2.14M |
|
|
VPU
2699
Vanguard Utilities ETF
VPU
$8.46B
| $697K | ﹤0.01% |
4,900
-3,000
| -38% | -$439K |
|
2700
ClearOne Inc
CLRO
$10.9M
| $694K | ﹤0.01% |
55,871
+25,827
| +86% | +$544K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.